Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

Kirsten E. Peters, Wendy A. Davis, Jun Ito, Kaye Winfield, Thomas Stoll, Scott D. Bringans, Richard J. Lipscombe and Timothy M.E. Davis. Diabetes Care.

Conclusions

The current study has identified novel plasma biomarkers (apoA4, CD5L, C1QB, and IBP3) that may improve the prediction of rapid decline in renal function independently of recognized clinical risk factors in type 2 diabetes.

Article